Drug Report History #73405
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v13-FR | |
|---|---|---|
| Language (Changed) | Updated to: English | Was: French |
| Date Updated (Changed) | Updated to: 2020-07-14 | Was: 2020-06-30 |
| Drug Identification Number | 02246414 | 02246414 |
| Brand name | AVELOX I.V. | AVELOX I.V. |
| Common or Proper name | Moxifloxacin Injection | Moxifloxacin Injection |
| Company Name | BAYER INC | BAYER INC |
| Ingredients | MOXIFLOXACIN | MOXIFLOXACIN |
| Strength(s) | 400MG | 400MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 250 mL | 250 mL |
| Additional packaging sizes | ||
| ATC code | J01MA | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS | QUINOLONE ANTIBACTERIALS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2020-07-03 | 2020-07-03 |
| Actual discontinuation date (Changed) | Updated to: 2020-06-29 | Was: |
| Remaining supply date | 2020-07-03 | 2020-07-03 |
| Discontinuation status (Changed) | Updated to: Discontinued | Was: To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |